.png){kind=icon}
返回
Optimized Hypofractionation Can Markedly Improve Tumor Control and Decrease Late Effects for Head and Neck Cancer
.png){kind=icon}
PRE
AI
DOI：10.1016/j.ijrobp.2019.02.025.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Purpose: Treatment of fast-growing, human papillomavirus-negative, head and neck cancers (HNCs) remains challenging from the perspectives of both tumor control and late sequelae. In this study, we use systematic radiobiological optimization to identify fractionation schemes that markedly improve the radiotherapeutic effectiveness balance between tumor control probability (TCP) and late normal tissue complication probability (LNTCP), as compared with standard fractionation. Methods and Materials: We track the development after each treatment fraction of both tumor control and late sequelae. Toward the end of the treatment, accelerated repopulation of fast-growing HNC tumors means that further fractions minimally improve TCP but result in major LNTCP increases, providing the potential for optimization of the TCP-LNTCP balance. We used a recent improved model of accelerated repopulation, calibrated with extensive HNC clinical trials data, to identify optimally effective treatment regimens that both increase TCP and significantly decrease LNTCP. For comparison, we also used standard repopulation models. Results: An optimized hypofractionated schedule of 18 x 3.0 Gy is predicted to substantially increase TCP, particularly for late-stage HNC tumors (eg, similar to 35% to 49% for late-stage tumors) while decreasing high-grade LNTCP (eg, similar to 13% to <2%), as compared with a standard 35 x 2.0 Gy protocol. In addition, the treatment time is reduced from 47 to 24 days. Twice-daily treatments of 1.8 Gy per fraction provide still better outcomes. The hypofractionation predictions are robust, being almost independent of the details of the repopulation model. Conclusions: Hypofractionation or its close variant, accelerated hyperfractionation, efficiently overcomes tumor repopulation in fast-growing tumors and can be optimized toward the end of treatment when repopulation causes the TCP to increase only very slowly while LNTCP increases rapidly. Radiobiological modeling suggests that optimized 3.0 Gy per fraction hypofractionation (or 1.8 Gy per fraction, 2 fractions per weekday, accelerated hyperfractionation) is considerably more effective for HNC tumor control and for reduction of late effects than standard 2.0-Gy fractionation. (C) 2019 Elsevier Inc. All rights reserved.
Keyword:
SQUAMOUS-CELL CARCINOMAS
LOCALLY ADVANCED HEAD
RADIATION-THERAPY
RANDOMIZED-TRIAL
CONVENTIONAL RADIOTHERAPY
ACCELERATED FRACTIONATION
HUMAN-PAPILLOMAVIRUS
REGIONAL CONTROL
TOXICITY
HYPERFRACTIONATION
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
I
IF:
6.5
论文数:
4.8W
被引数:
4.2W
机构
引用论文
Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis限期小细胞肺癌每日两次胸部放疗不会增加急性重度食管炎的发生率.png)
CLINICAL LUNG CANCER
CLINICAL LUNG CANCERIF3.3
PREAI
分享收藏
Optimization of the fractionated irradiation scheme considering physical doses to tumor and organ at risk based on dose-volume histograms基于剂量体积直方图的考虑对肿瘤和危险器官的物理剂量的分次照射方案的优化MEDICAL PHYSICS
OAAI
MEDICAL PHYSICSIF3.2
OAAI分享收藏
查看更多内容